Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 2
2013 2
2016 1
2017 1
2019 1
2020 6
2021 8
2022 7
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Moving towards establishing centres of excellence in cardiac amyloidosis: an International Cardio-Oncology Society statement.
Cheng R, Kittleson MM, Wechalekar AD, Alvarez-Cardona J, Mitchell JD, Scarlatelli Macedo AV, Dutra JPP, Campbell CM, Liu JE, Landau HJ, Davis MK, Morrissey S, Casselli S, Lousada I, Seabra-Garcez JD, Szor RS, Ganatra S, Trachtenberg B, Maurer MS, Stockerl-Goldstein K, Lenihan D. Cheng R, et al. Among authors: campbell cm. Heart. 2024 Jan 24:heartjnl-2023-323502. doi: 10.1136/heartjnl-2023-323502. Online ahead of print. Heart. 2024. PMID: 38267197 Review.
Targeted Therapeutics for Transthyretin Amyloid Cardiomyopathy.
Campbell CM, Baiyee CAMT, Almaani S, Bumma N, Sharma N, LoRusso S, Redder E, Bittengle J, Pfund K, Friemer M, Tong M, Kahwash R, Efebera Y, Parikh S, Vallakati A. Campbell CM, et al. Am J Ther. 2023 Sep-Oct 01;30(5):e447-e453. doi: 10.1097/MJT.0000000000001296. Epub 2021 Nov 23. Am J Ther. 2023. PMID: 37713689
Delayed Diagnosis and Recovery of Fulminant Immune Checkpoint Inhibitor-Associated Myocarditis on VA-ECMO Support.
Ramayya T, Mitchell JD, Hartupee JC, Lavine K, Ridley CH, Kotkar KD, Jimenez J, Lin CY, Alvarez-Cardona JA, Krone RK, Campbell CM. Ramayya T, et al. Among authors: campbell cm. JACC CardioOncol. 2022 Dec 20;4(5):722-726. doi: 10.1016/j.jaccao.2022.08.013. eCollection 2022 Dec. JACC CardioOncol. 2022. PMID: 36636445 Free PMC article. Review.
Multidisciplinary amyloidosis care in the era of personalized medicine.
Bumma N, Kahwash R, Parikh SV, Isfort M, Freimer M, Vallakati A, Redder E, Campbell CM, Sharma N, Efebera Y, Stino A. Bumma N, et al. Among authors: campbell cm. Front Neurol. 2022 Oct 13;13:935936. doi: 10.3389/fneur.2022.935936. eCollection 2022. Front Neurol. 2022. PMID: 36341129 Free PMC article. Review.
Beta-Adrenergic Antagonist Tolerance in Amyloid Cardiomyopathy.
Ramsell S, Arias Bermudez C, Takem Baiyee CAM, Rodgers B, Parikh S, Almaani S, Sharma N, LoRusso S, Freimer M, Redder E, Bumma N, Vallkati A, Efebera Y, Kahwash R, Campbell CM. Ramsell S, et al. Among authors: campbell cm. Front Cardiovasc Med. 2022 Jul 11;9:907597. doi: 10.3389/fcvm.2022.907597. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35898273 Free PMC article.
Developing Therapy for Transthyretin Amyloidosis.
Campbell CM, Zhang K, Lenihan DJ, Witteles R. Campbell CM, et al. Am J Med. 2022 Apr;135 Suppl 1:S44-S48. doi: 10.1016/j.amjmed.2022.01.002. Epub 2022 Jan 22. Am J Med. 2022. PMID: 35077703 Review.
29 results